text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nUnins(H.K.) International Limited(*1)\n비상장\n1997.01.01\n경영참여\n549\n4,638,000\n100.00\n159\n-\n-\n-\n4,638,000\n100.00\n159\n148\n-1\n(주)한독테바\n비상장\n2013.02.21\n경영참여\n7,350\n15,680\n49.00\n23,520\n-\n-\n-\n15,680\n49.00\n23,520\n27,803\n-5,553\n(주)제넥신\n상장\n2013.10.26\n경영참여\n29,021\n3,781,017\n15.04\n51,859\n2,267,517\n12,814\n-\n6,048,534\n14.57\n64,673\n376,587\n-66,860\n(주)칼로스메디칼(*2)\n비상장\n2015.10.01\n경영참여\n1,017\n178,862\n49.96\n996\n-\n-\n-\n178,862\n49.96\n996\n1,236\n-5,861\n(주)엔비포스텍\n비상장\n2016.03.14\n경영참여\n8,400\n1,100,010\n34.99\n3,835\n\xa0571,429\n\xa01,538\n-874\n1,671,439\n34.61\n4,499\n3,528\n-3,586\nRezolute, INC.(*4)\n상장\n2019.01.28\n경영참여\n13,964\n5,942,617\n16.14\n43,006\n-\n-\n-\n5,942,617\n15.00\n43,006\n218,692\n-52,101\nTheravalues Corporation\xa0\n비상장\n2016.12.12\n경영참여\n21,304\n1,750,000\n100.00\n17,186\n-\n-\n-\n1,750,000\n100.00\n17,186\n6,334\n311\nMac Fund, L.P.(*3)\n비상장\n2013.01.08\n단순투자\n1,064\n-\n10.60\n465\n-\n-\n-\n-\n10.60\n465\n4,912\n-458\nRMGP Bio-Pharma Investment Fund L.P(*4)\n비상장\n2017.04.28\n단순투자\n4,780\n-\n18.86\n5,916\n-\n\xa0 549\n-952\n\xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n18.86\n5,513\n30,339\n-6,753\nHD Medical, Inc.(*4)\n비상장\n2017.06.28\n일반투자\n568\n188,844\n3.16\n-\n-\n-\n-\n188,844\n3.16\n-\n393\n-896\nSANA Health. INC.(*4)\n비상장\n2018.08.24\n일반투자\n281\n118,021\n1.05\n-\n-\n-\n-\n118,021\n1.05\n-\n5,170\n-6,741\nBiomX Ltd.(*4)\n상장\n2018.11.16\n일반투자\n2,929\n399,399\n1.33\n94\n-\n-\n\xa050\n399,399\n0.87\n144\n57,701\n-36,584\nSCM생명과학(주)(*4)\n상장\n2019.05.24\n일반투자\n4,000\n141,048\n1.17\n2,038\n-\n-\n-1,398\n141,048\n1.17\n640\n33,020\n-22,930\nAdicet Bio, Inc.(*4)\n상장\n2019.07.25\n일반투자\n3,534\n290,454\n0.68\n3,291\n-\n-\n-2,583\n290,454\n0.68\n708\n491,083\n-90,165\n인터베스트오픈 이노베이션 사모투자합작회사(*4)\n비상장\n2020.12.30\n단순투자\n1,500\n-\n6.25\n9,750\n-\n3,000\n-\n-\n6.25\n12,750\n149,557\n-3,559\n웰트(주)\n비상장\n2021.03.24\n일반투자\n3,001\n5,486\n9.94\n3,001\n\xa0 \xa0 \xa0 255\n\xa0 \xa0601\n-\n5,741\n9.94\n3,602\n13,813\xa0\n-2,128\xa0\nCompass Therapeutics, Inc.(*4)\n상장\n2021.06.24\n일반투자\n9,094\n2,032,269\n1.61\n12,954\n-\n-\n-8,866\n2,032,269\n1.59\n4,088\n253,010\n-50,677\n(주)이노큐브\n비상장\n2021.09.07\n경영참여\n200\n30,857\n72.97\n4,000\n-\n-\n-\n30,857\n72.97\n\xa0 4,000\n8,303\n-506\n스파크바이오파마(주)\n비상장\n2021.11.26\n일반투자\n3,000\n46,512\n2.01\n3,000\n-\n-\n-\n46,512\n2.00\n\xa0 \xa03,000\n18,535\n-11,241\nImmPACT Bio USA Inc.\n비상장\n2022.01.24\n일반투자\n1,319\n70,479\n0.55\n1,319\n-\n-\n-\n70,479\n0.55\n\xa0 1,319\n76,374\n-26,351\n이노헬스펀드1호\n비상장\n2023.03.08\n경영참여\n500\n-\n-\n-\n50\n500\n-\n50\n33.33\n\xa0 \xa0 \xa0500\n1,505\n-23\nAum Biosciences Pte. Ltd.\n비상장\n2023.04.04\n일반투자\n967\n-\n-\n-\n51,508\n987\n-\n51,508\n0.52\n\xa0 \xa0 \xa0987\n3,189\n-11,202\n㈜닥터다이어리\n비상장\n2023.04.06\n일반투자\n2,005\n-\n-\n-\n383\n2,005\n-\n383\n3.10\n\xa0 2,005\n12,942\n-4,593\n합 계\n-\n-\n186,389\n-\n21,994\n-14,623\n-\n-\n193,760\n-\n-\n※ 피출자법인의 최근사업연도 총자산 및 당기순손익은 최근사업연도 기말잔액 및 실적을 기재하였습니다.(*1) Unins(H.K.) International Limited는 3월 결산법인으로 최근사업연도 재무현황은 2023년 3월 31일 기준으로 기재하였습니다.\n(*2) (주)칼로스메디칼 지분율의 경우 우선주를 제외한 비율입니다.(*3) Mac Fund, L.P.는 청산 절차 진행 중에 있습니다.(*4) 해당 법인들의 경우 최근 사업연도 기말잔액 및 실적 확보가 어려워 확보 가능한 가장 최근의 자료를 기재하였습니다.\n']"
